Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EQUIFAX INCEFX · Entity 3235 | EVP, CFO & COO | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EQUIFAX INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,055 |
Reported balance
After 2026-09-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-03 · Sale · Disposed 4,500 · Balance 69,055 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CyrusOne Inc.
Report date March 25, 2022 · Filed March 25, 2022
Section 16 reporting ended · disclosed 2022-03-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-03-25 transaction · row 1
1 source rowRow 1 · 2022-03-25 · Disposition to issuer · Disposed 26,353 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of November 14, 2021, by and among CyrusOne Inc., a Maryland corporation, Cavalry Parent L.P., a Delaware limited partnership ("Parent"), and Cavalry Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent, at the effective time of the merger (the "Effective Time"), (i) each share of Common Stock converted into the right to receive a lump-sum cash payment, without interest, equal to $90.50 (the "Merger Consideration") and (ii) each outstanding restricted share became fully vested and was canceled and converted into the right to receive the Merger Consideration, plus the amount of any accrued dividends with respect to such restricted shares that remain unpaid as of the Effective Time. The amount includes 142 shares acquired pursuant to the Issuer's dividend reinvestment program. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of November 14, 2021, by and among CyrusOne Inc., a Maryland corporation, Cavalry Parent L.P., a Delaware limited partnership ("Parent"), and Cavalry Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent, at the effective time of the merger (the "Effective Time"), (i) each share of Common Stock converted into the right to receive a lump-sum cash payment, without interest, equal to $90.50 (the "Merger Consideration") and (ii) each outstanding restricted share became fully vested and was canceled and converted into the right to receive the Merger Consideration, plus the amount of any accrued dividends with respect to such restricted shares that remain unpaid as of the Effective Time. The amount includes 142 shares acquired pursuant to the Issuer's dividend reinvestment program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 862 | $162.33 | $139,930.44 |
DisclosureSEC source: 0001225208-22-011215 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,692 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/22/2022. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $161.71 to $162.635, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 519 | $163.28 | $84,739.78 |
DisclosureSEC source: 0001225208-22-011215 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,554 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/22/2022. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $162.885 to $163.61, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 25, 2022 Filed Mar 25, 2022 20:29 UTC | CyrusOne Inc. CONE · Entity 128768 | Disposition to issuerCommon Stock | 26,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-038118 · tm2210242-6_4seq1.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to the Agreement and Plan of Merger, dated as of November 14, 2021, by and among CyrusOne Inc., a Maryland corporation, Cavalry Parent L.P., a Delaware limited partnership ("Parent"), and Cavalry Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent, at the effective time of the merger (the "Effective Time"), (i) each share of Common Stock converted into the right to receive a lump-sum cash payment, without interest, equal to $90.50 (the "Merger Consideration") and (ii) each outstanding restricted share became fully vested and was canceled and converted into the right to receive the Merger Consideration, plus the amount of any accrued dividends with respect to such restricted shares that remain unpaid as of the Effective Time. The amount includes 142 shares acquired pursuant to the Issuer's dividend reinvestment program. F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of November 14, 2021, by and among CyrusOne Inc., a Maryland corporation, Cavalry Parent L.P., a Delaware limited partnership ("Parent"), and Cavalry Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent, at the effective time of the merger (the "Effective Time"), (i) each share of Common Stock converted into the right to receive a lump-sum cash payment, without interest, equal to $90.50 (the "Merger Consideration") and (ii) each outstanding restricted share became fully vested and was canceled and converted into the right to receive the Merger Consideration, plus the amount of any accrued dividends with respect to such restricted shares that remain unpaid as of the Effective Time. The amount includes 142 shares acquired pursuant to the Issuer's dividend reinvestment program. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 11,324 | $212.24 | $2,403,405.76 |
DisclosureSEC source: 0001225208-22-003262 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,024 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 21,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003262 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,348 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:33 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 14,434 | $0.00 Strike: $225.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002186 · doc4.xml · derivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,434 Underlying: Common Stock · 14,434 shares Expires 2032-02-11 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:33 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002186 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,374 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 20:18 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,887 | $258.29 | $487,393.23 |
DisclosureSEC source: 0001225208-21-010924 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,740 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:29 UTC | CyrusOne Inc. CONE · Entity 128768 | GrantCommon Stock | 2,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001553023-21-000059 · wf-form4_162154973261716.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,883.71 F1 · shares: Annual equity retainer grant of restricted stock. The restricted stock vests on the earlier of the the first anniversary of the grant date or the date immediately prior to the next annual meeting of stockholders. F2 · balance_after: Includes 582.66 shares acquired pursuant to the Issuer's dividend reinvestment plan. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:20 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 5,561 | $169.75 | $943,979.75 |
DisclosureSEC source: 0001225208-21-004918 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,573 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:20 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 9,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004918 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,134 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:22 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 9,877 | $0.00 Strike: $177.19 | $0.00 |
DisclosureSEC source: 0001225208-21-002793 · doc4.xml · derivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,877 Underlying: Common Stock · 9,877 shares Expires 2031-02-12 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/12/2022. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:22 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002793 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,687 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/12/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 11,337 | $165.09 | $1,871,657.07 |
DisclosureSEC source: 0001225208-20-010115 · doc4.xml · nonDerivative · entry 4 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,164 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $164.61 to $165.54, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 4,066 | $164.31 | $668,069.01 |
DisclosureSEC source: 0001225208-20-010115 · doc4.xml · nonDerivative · entry 3 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,501 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $163.61 to $164.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,426 | $163.10 | $232,579.03 |
DisclosureSEC source: 0001225208-20-010115 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,567 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $162.45 to $163.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 671 | $165.67 | $111,166.05 |
DisclosureSEC source: 0001225208-20-010115 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,993 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $165.61 to $165.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:02 UTC | CyrusOne Inc. CONE · Entity 128768 | GrantCommon Stock | 2,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001553023-20-000094 · wf-form4_158862616062550.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,264.0477 F1 · shares: Annual equity retainer grant of restricted stock. The restricted stock vests on the earlier of the the first anniversary of the grant date or the date immediately prior to the next annual meeting of stockholders. F2 · balance_after: Includes 700.128 shares acquired pursuant to the Issuer's dividend reinvestment plan. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:56 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 8,208 | $0.00 Strike: $175.48 | $0.00 |
DisclosureSEC source: 0001225208-20-003460 · doc4.xml · derivative · entry 3 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,208 Underlying: Common Stock · 8,208 shares Expires 2026-02-21 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:56 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 10,355 | $0.00 Strike: $191.44 | $0.00 |
DisclosureSEC source: 0001225208-20-003460 · doc4.xml · derivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,355 Underlying: Common Stock · 10,355 shares Expires 2026-02-21 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:56 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003460 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,602 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 710 | $161.88 | $114,934.80 |
DisclosureSEC source: 0001225208-20-003093 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,251 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003093 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,961 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 22:02 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,217 | $159.63 | $194,269.71 |
DisclosureSEC source: 0001225208-20-002779 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,388 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 16,512 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001225208-19-003789 · doc4.xml · derivative · entry 4 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,512 Underlying: Common Stock · 16,512 shares Expires 2025-02-22 F3 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 19,965 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001225208-19-003789 · doc4.xml · derivative · entry 3 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965 Underlying: Common Stock · 19,965 shares Expires 2025-02-22 F3 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 24,069 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001225208-19-003789 · doc4.xml · derivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,069 Underlying: Common Stock · 24,069 shares Expires 2025-02-22 F3 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003789 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,456 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/22/2022. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 22:06 UTC | CyrusOne Inc. CONE · Entity 128768 | GrantCommon Stock | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001553023-19-000061 · wf-form4_155113237342007.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,424.9197 F1 · shares: Annual equity retainer in the form of restricted stock vesting in full on the first anniversary of the grant date. F2 · balance_after: Includes 511.9197 shares acquired pursuant to the Issuer's dividend reinvestment plan. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 21:50 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 3,004 | $109.32 | $328,397.28 |
DisclosureSEC source: 0001225208-19-003069 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,409 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 21:50 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003069 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,413 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 20:52 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 16,196 | $0.00 Strike: $123.49 | $0.00 |
DisclosureSEC source: 0001225208-18-012074 · doc4.xml · derivative · entry 3 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,196 Underlying: Common Stock · 16,196 shares Expires 2028-07-27 F3 · derivative.exercise_date: Special equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 7/27/2019. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 20:52 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 4,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-012074 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,986 F1 · security: Special equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 7/27/2021. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:20 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 11,128 | $0.00 Strike: $121.35 | $0.00 |
DisclosureSEC source: 0001225208-18-005685 · doc4.xml · derivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,128 Underlying: Common Stock · 11,128 shares Expires 2028-03-05 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 3/5/2019. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:20 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-005685 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,903 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 3/5/2021. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:11 UTC | CyrusOne Inc. CONE · Entity 128768 | GrantCommon Stock | 2,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001553023-18-000041 · wf-form4_151985949833032.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,530 F1 · shares: Annual equity retainer in the form of restricted stock vesting in full on the first anniversary of the grant date. F2 · balance_after: Includes 262 shares acquired pursuant to the Issuer's dividend reinvestment plan. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:35 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 8,550 | $117.46 | $1,004,283.00 |
DisclosureSEC source: 0001225208-18-003599 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,122 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in the corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:35 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 14,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003599 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,672 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in the corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:21 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 6,500 | $145.60 | $946,374.00 |
DisclosureSEC source: 0000899243-17-019691 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,078 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $145.56 to $145.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:15 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 14,000 | $136.44 | $1,910,132.00 |
DisclosureSEC source: 0001225208-17-010359 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,578 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $136.24 to $136.71, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. Read SEC document |
| May 21, 2017 Filed May 22, 2017 20:04 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 47,337 | $136.37 | $6,455,346.69 |
DisclosureSEC source: 0001225208-17-010196 · doc4.xml · nonDerivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,578 Read SEC document |
| May 21, 2017 Filed May 22, 2017 20:04 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 18,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-010196 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,915 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 11:01 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 10,385 | $0.00 Strike: $129.93 | $0.00 |
DisclosureSEC source: 0001225208-17-003810 · doc4.xml · derivative · entry 2 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,385 Underlying: Common Stock · 10,385 shares Expires 2027-02-16 F2 · derivative.exercise_date: The option vests in three equal annual increments beginning 2/16/2018. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 11:01 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003810 · doc4.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · CVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,179 F1 · security: Award of restricted stock units. The stock vests 100% on 2/16/2020. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 23:57 UTC | CyrusOne Inc. CONE · Entity 128768 | GrantCommon Stock | 2,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001553023-17-000044 · wf-form4_148720301370894.xml · nonDerivative · entry 1 GAMBLE JOHN W JR · CIK 0001222712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,832 F1 · shares: Annual equity retainer in the form of restricted stock vesting in full on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.